Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viemed Healthcare Inc., 3 years.
Viemed Healthcare Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 19, 2026 | Viemed Healthcare Inc. | Option exercise | +18,786 | — | — |
| Aug 20, 2025 | Viemed Healthcare Inc. | Option exercise | +15,732 | — | — |
| Jun 30, 2025 | Viemed Healthcare Inc. | Option exercise | +7,048 | $6.63 | $46,728 |
| Jun 30, 2025 | Viemed Healthcare Inc. | Open-market sale | −7,048 | $6.91 | $48,702 |
| Jun 27, 2025 | Viemed Healthcare Inc. | Option exercise | +34,100 | $6.63 | $226,083 |
| Jun 27, 2025 | Viemed Healthcare Inc. | Open-market sale | −34,100 | $7.01 | $239,041 |
| Jun 26, 2025 | Viemed Healthcare Inc. | Option exercise | +8,852 | $6.63 | $58,689 |
| Jun 26, 2025 | Viemed Healthcare Inc. | Open-market sale | −8,852 | $7.00 | $61,964 |
| Nov 26, 2024 | Viemed Healthcare Inc. | Option exercise | +5,995 | $2.50 | $14,988 |
| Nov 26, 2024 | Viemed Healthcare Inc. | Open-market sale | −5,995 | $8.58 | $51,437 |
| Nov 25, 2024 | Viemed Healthcare Inc. | Option exercise | +24,005 | $2.50 | $60,013 |
| Nov 25, 2024 | Viemed Healthcare Inc. | Open-market sale | −24,005 | $8.70 | $208,844 |
| Nov 20, 2024 | Viemed Healthcare Inc. | Option exercise | +15,000 | $2.50 | $37,500 |
| Nov 20, 2024 | Viemed Healthcare Inc. | Open-market sale | −15,000 | $8.50 | $127,500 |
| Nov 19, 2024 | Viemed Healthcare Inc. | Option exercise | +15,000 | $2.50 | $37,500 |
Questions about Nitin Kaushal
What boards is Nitin Kaushal on?
Nitin Kaushal sits on the board of Viemed Healthcare Inc.
How long has Nitin Kaushal served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.